Reply to: "Bridging the treatment gap in patients at 'extreme' cardiovascular risk: Evidence from a lipid clinic".

Rallidis, Loukianos S; Kiouri, Estela; Rallidi, Maria; Kosmas, Nikolaos

Rallidis, Loukianos S; Kiouri, Estela; Rallidi, Maria; Kosmas, Nikolaos.

Afiliação

Rallidis LS; Second Department of Cardiology, University General Hospital Attikon, Athens, Greece. Electronic address: lrallidis@gmail.com.
Kiouri E; Second Department of Cardiology, University General Hospital Attikon, Athens, Greece.
Rallidi M; Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.
Kosmas N; Second Department of Cardiology, University General Hospital Attikon, Athens, Greece.

Atherosclerosis ; 281: 219-220, 2019 02.

Article em En | MEDLINE | ID: mdl-30551893

Assuntos

Anticolesterolemiantes; Doenças Cardiovasculares; LDL-Colesterol; Humanos; Lipídeos; Prevalência; Fatores de Risco

Palavras-chave

Coronary artery disease; Extreme CVD risk category; High-intensity lipid-lowering therapy; LDL cholesterol target

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Anticolesterolemiantes Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google